YNYuri Nakamura

Yuri Nakamura

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yuri Nakamura has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Improving Diagnostic Accuracy for Peripheral Neuropathy: Use of Tibial Nerve Somatosensory Evoked Potentials

    by Miki Oka, Shozo Tobimatsu, Akira Yokote, Ayako Sakoda, Saeko Inamizu, Yuri Nakamura, Keiko Haro, Yuki Yanagihara, Yasutaka Iwanaga, Ken-Ichiro Yamashita, et al.

    Background: We investigated whether combining a sural nerve sensory conduction study (s-SCS) and tibial nerve SEPs (t-SEPs) improves diagnostic accuracy for peripheral sensory neuropathy. Methods: We retrospectively reviewed 74 consecutive cases (114 lower limbs) of patients suspected of having neuropathy or radiculopathy who underwent s-SCSs and t-SEPs between July 2021 and December 2024. Abnormal S-SCSs were defined as a reduction in amplitude or a slowing of conduction velocity. Abnormal t-SEPs were defined as failure to evoke N20 or P37, or prolonged latency of either. Results: No cases showed s-SCS abnormalities with normal t-SEPs. Then, we classified the groups based on the combination of abnormality of s-SCSs and t-SEPs. Group 1 (G1) had normal s-SCSs and normal t-SEPs, which were observed in 31 limbs (27.2%). Group 2 (G2) had normal s-SCSs and abnormal t-SEPs, which were found in 45 limbs (39.5%). Subgroups of G2 included normal N20 with abnormal P37, abnormal N20 with normal P37, and N20/P37 abnormalities. Group 3 (G3) had abnormal s-SCSs with abnormal t-SEPs, which were seen in 38 limbs (33.3%). Conclusions: Electrophysiological testing reveals normal distal and proximal sensory nerves in G1, suggesting preserved sensory nerve function. The distal sensory nerves are normal in G2. However, abnormal N20/P37 and abnormal N20 with normal P37 indicate proximal sensory nerve involvement. Normal N20 with abnormal P37 indicates posterior column dysfunction. In G3, both the distal and proximal sensory nerve segments are abnormal. Therefore, adding t-SEPs to s-SCSs allows us to evaluate the full length of the peripheral nerves, which is useful for diagnosis and assessing treatment efficacy.

  • Open Access

    Improving Diagnostic Accuracy for Peripheral Neuropathy: Use of Tibial Nerve Somatosensory Evoked Potentials

    by Miki Oka, Shozo Tobimatsu, Akira Yokote, Ayako Sakoda, Saeko Inamizu, Yuri Nakamura, Keiko Haro, Yuki Yanagihara, Yasutaka Iwanaga, Ken-Ichiro Yamashita, et al.

    Background: We investigated whether combining sural nerve sensory conduction study (s-SCS) and tibial nerve SEPs (t-SEPs) improves diagnostic accuracy for peripheral sensory neuropathy. Methods: We retrospectively reviewed 74 consecutive cases (114 lower limbs) of patients suspected of having neuropathy or radiculoneuropathy who underwent s-SCS and t-SEPs between July 2021 and December 2024. Abnormal s-SCS was defined as an amplitude 44.35 ms. Results: No cases showed s-SCS abnormalities with normal t-SEPs. Group 1 (G1) had normal s-SCS and normal t-SEPs, which were observed in 31 limbs (27.2%). Group 2 (G2) had normal s-SCSs and abnormal t-SEPs, which were found in 45 limbs (39.5%). Subgroups of G2 included normal N20 with abnormal P37, abnormal N20 with normal P37 and N20/P37 abnormalities. Group 3 (G3) had abnormal s-SCSs with abnormal t-SEPs, which was seen in 38 limbs (33.3%). Conclusions: Electrophysiological testing reveals normal distal and proximal sensory nerves in G1, suggesting preserved sensory nerve function. The distal sensory nerves are normal in G2. However, abnormal N20/P37 and abnormal N20 with nP37 indicate proximal sensory nerve involvement. Normal N20 with abnormal P37 indicates posterior column dysfunction. In G3, both the distal and proximal sensory nerve segments are abnormal. Therefore, adding t-SEPs to s-SCSs allows us to evaluate the full length of the peripheral nerves, which is useful for diagnosis and assessing treatment efficacy.

  • Open Access

    Spinal cord involvement by atrophy and associations with disability are different between multiple sclerosis and neuromyelitis optica spectrum disorder

    by Y. Nakamura, Z. Liu, S. Fukumoto, K. Shinoda, A. Sakoda, T. Matsushita, S. Hayashida, N. Isobe, M. Watanabe, A. Hiwatashi, et al.

    Background and purpose The cervical and thoracic cross‐sectional spinal cord area (CS‐SCA) in multiple sclerosis (MS) correlates with disability, whilst such a correlation remains to be established in neuromyelitis optica spectrum disorder (NMOSD). Our aim was to clarify differences between MS and NMOSD in spinal cord segments where CS‐SCA is associated with disability. Methods The CS‐SCA at C2/C3, C3/C4, T8/T9 and T9/T10 vertebral disc levels was measured in 140 MS patients (111 with relapsing–remitting MS and 29 with progressive MS) and 42 NMOSD patients with anti‐aquaporin‐4 immunoglobulin G. Disability was evaluated by Expanded Disability Status Scale (EDSS) scores. Multivariate associations between CS‐SCA and disability were assessed by stepwise forward multiple linear regression. Results Thoracic CS‐SCA was significantly smaller in NMOSD patients than in MS patients even after adjusting for age, sex and disease duration (P  =  0.002 at T8/T9), whilst there was no difference in cervical CS‐SCA between the two diseases. Cervical and thoracic CS‐SCA had a negative correlation with EDSS scores in MS patients (P  <  0.0001 at C3/C4 and P  =  0.0002 at T8/T9) whereas only thoracic CS‐SCA correlated with EDSS scores in NMOSD patients (P  =  0.0006 at T8/T9). By multiple regression analyses, predictive factors for disability in MS were smaller cervical CS‐SCA, progressive course, older age and a higher number of relapses, whilst those in NMOSD were smaller thoracic CS‐SCA and older age. Conclusions Thoracic CS‐SCA is a useful predictive marker for disability in patients with NMOSD whilst cervical CS‐SCA is associated with disability in patients with MS.